Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...
New capability enables more precise prostate cancer detection, a major advancement for men's health across Idaho No one ...
High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6%, respectively), a ...
A trial found no meaningful difference in detection of clinically significantly prostate cancer between multiparametric MRI-based and microultrasound-based biopsy techniques.
MARKHAM, Ontario--(BUSINESS WIRE)--Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro-ultrasound platform to MRI ...
For men with elevated prostate-specific antigen (PSA) levels who are at average risk for prostate cancer, evaluating suspicious lesions with MRI-directed targeted biopsy instead of systematic biopsy ...
Role of urinary exosomal FAM153C-RPL19 in detection and risk stratification of prostate cancer: A multicentre Chinese cohort study. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...
Omitting biopsy in patients with a negative prostate MRI more than halves the diagnoses of clinically insignificant prostate cancer. Detection of clinically insignificant ISUP grade group 1 prostate ...
Biparametric MRI, which omits dynamic contrast-enhanced sequences, similarly detected clinically significant prostate cancer to multiparametric MRI. Biparametric MRI was also noninferior to ...
Koelis, SAS (“Koelis” or the “Company”, a global leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, announced today the official launch of its new software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results